Partnering with InformedDNA

Proven expertise applying genetics to clinical trials, clinical research programs and natural history studies

Partner with our genetics experts to derive the most value from your research and improve the identification, recruitment and engagement of patients eligible for clinical trials.

With the rise in precision medicine, clinical trial protocols and post-market programs have become increasingly complex, leading to greater opportunities by integrating genetics and genomics expertise.

Our team of genetics experts are experienced in working with leading pharmaceutical companies to develop and implement genetics- informed strategies to improve your clinical trial outcomes. Our optimized offerings remove these obstacles by:

  • Reducing time to enrollment
  • Improving patient identification, recruitment, and engagement
  • Deriving the most value from research and genetic data
  • Ensuring post-market success


View our FierceBiotech Webinar

Why Pharma & Biopharma sponsors partner with InformedDNA

  • More than half of clinical trials incorporate genetic testing. It’s more important than ever to work with an experienced team of clinical genetics specialists like ours.

  • Genetic testing lends itself to inefficient processes and high-cost programs. Our services help to reduce clinical trial costs, and reduce the time to enrollment of these trials, thereby helping to increase margins.

  • We specialize in rare genetic diseases. The expertise in this area and our longevity as a leading genetics services provider allows us to leverage a database of nearly 100,000 physicians who order genetic tests.

  • Our unbiased approach towards test ordering empowers us to determine the right test for the right patient at the best lab.

  • Effective management of precision medicine requires policies and claims systems – we help you integrate these with diagnostic and therapeutic activities.

We help clients improve outcomes, while mitigating risks and costs.



Optimize patient identification and maximize market insights by uncovering targeted populations at the community level and leveraging proven telegenetics methods to screen clinical trial candidates.

  • Nationwide rare disease network
  • Proven recruitment and pre-screening process
  • High-touch patient screening
  • Expert genetic testing program design
  • Assurance for regulatory compliance
  • Valuable reporting insights


Ensure post-market success by identifying rare disease therapy candidates in their communities and ensuring successful coverage policies with payers.

  • Nationwide rare disease network
  • Proven pre-screening process
  • Deep payer relationships
  • Expert genetic testing program design
  • Optimized data for FDA review
  • Valuable reporting insights


Utilize trusted IRB-approved screening programs to simplify the genetic testing process and reduce barriers to clinical trial enrollment.

  • Full-service study coordination
  • High-touch genetic testing program
  • Established healthcare provider relationships
  • Valuable reporting insights

“Forging new pathways to support clinical development in genetics and precision medicine is critical to help create a world where no life is limited by genetic disease. The efforts of WCG and InformedDNA to ensure access to genetic testing and counseling are an essential step to support the clinical development of genetic medicines and could benefit millions of patients suffering from rare and genetic diseases.”

– Head of Global Commercial at a leading pharmaceutical company
that worked with InformedDNA as they prepared for the first FDA approval
for a gene therapy for a genetic disease.

Let's talk about how we can meet
your genetics services needs.